Exact Sciences Corporation
EXAS
$47.76
$0.811.73%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.83B | 2.76B | 2.69B | 2.61B | 2.53B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.83B | 2.76B | 2.69B | 2.61B | 2.53B |
| Cost of Revenue | 876.29M | 861.25M | 832.30M | 804.76M | 771.90M |
| Gross Profit | 1.95B | 1.90B | 1.86B | 1.81B | 1.76B |
| SG&A Expenses | 1.71B | 1.67B | 1.65B | 1.64B | 1.67B |
| Depreciation & Amortization | -23.31M | -23.31M | -21.10M | -22.55M | -22.93M |
| Other Operating Expenses | -- | -- | -2.03M | -2.03M | -2.03M |
| Total Operating Expenses | 2.99B | 2.94B | 2.91B | 2.88B | 2.86B |
| Operating Income | -163.65M | -178.55M | -213.98M | -269.03M | -323.50M |
| Income Before Tax | -1.03B | -1.04B | -210.57M | -172.10M | -237.67M |
| Income Tax Expenses | -8.89M | -7.30M | 3.47M | 2.91M | 2.55M |
| Earnings from Continuing Operations | -1.02K | -1.03K | -214.04 | -175.01 | -240.23 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.02B | -1.03B | -214.04M | -175.01M | -240.23M |
| EBIT | -163.65M | -178.55M | -213.98M | -269.03M | -323.50M |
| EBITDA | 51.33M | 36.31M | 1.90M | -55.66M | -112.69M |
| EPS Basic | -5.50 | -5.56 | -1.17 | -0.96 | -1.32 |
| Normalized Basic EPS | -0.55 | -0.60 | -0.67 | -0.89 | -1.09 |
| EPS Diluted | -5.51 | -5.57 | -1.18 | -0.96 | -1.32 |
| Normalized Diluted EPS | -0.55 | -0.60 | -0.67 | -0.88 | -1.09 |
| Average Basic Shares Outstanding | 741.23M | 736.77M | 732.57M | 728.43M | 724.32M |
| Average Diluted Shares Outstanding | 741.23M | 736.77M | 732.57M | 731.85M | 727.74M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |